Validation of a chemical osteoarthritis model in rabbit temporomandibular joint: a compliment to biomechanical models.

Int J Oral Maxillofac Surg

Laboratoire de Biomatériaux et Biomécanique ostéo-articulaire, UMR-CNRS 7052, 10, avenue de Verdun 75010, Paris, France.

Published: November 2006

To explore degenerative mechanisms occurring in the temporomandibular joint (TMJ), a chemical model of knee joint osteoarthritis using sodium mono-iodoacetate injection was transposed to the TMJ. Twelve New Zealand rabbits were used to document the effect of this drug on the TMJ. Eight rabbits underwent bilateral iodoacetate injection in the disco-condylar compartment while 4 served as controls. Rabbits were sacrificed at 10, 20, 30 and 40 days and joints studied by histology. Severity of the damage was time dependent and the use of iodoacetate allowed the observation, within a few weeks, of every osteoarthritic stage usually described in the literature. This study showed that the TMJ has a specific response to the degenerative process. This response was characterized by (i) thickening and fibrillation of the cartilage at the periphery of the lesion, tending to reduce mechanical stress in the lesional area and (ii) chondrocyte migration under areas where subchondral bone surface was locally destroyed. The extracellular matrix containing chondrocyte clusters and prechondrocytes dived around the bony defect and proceeded below the necrotic bone to promote the eviction of bony fragments into the joint cavity, pushing them up while the thickness of chondrocyte rows increased below. This could be interpreted as a repairing attempt due to the specific potential of fibrocartilage proliferative cells.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijom.2006.05.003DOI Listing

Publication Analysis

Top Keywords

temporomandibular joint
8
validation chemical
4
chemical osteoarthritis
4
osteoarthritis model
4
model rabbit
4
rabbit temporomandibular
4
joint
4
joint compliment
4
compliment biomechanical
4
biomechanical models
4

Similar Publications

Septic arthritis of the temporomandibular joint-a case report and review of the literature.

Front Oral Health

January 2025

Department of Oral and Maxillofacial Surgery, Tzafon Medical Center, Associate Professor at the Azrieli Faculty of Medicine, Bar-llan Univesity, Ramat Gan, Israel.

Septic arthritis occurring in the temporomandibular joint (TMJ) has received significantly less attention than it deserves. This condition can severely compromise joint functionality, especially if left untreated. Its typical presentation includes pain, fever, swelling, and the loss of TMJ functions.

View Article and Find Full Text PDF

Orthopedic management of a patient with synovial chondromatosis.

JAAPA

February 2025

Shawn C. Smith and Garrett M. Snyder practice in orthopedics in Loveland, Colo. The authors have disclosed no potential conflicts of interest, financial or otherwise.

This article reviews practice guidelines, diagnosis, and treatment for synovial chondromatosis, a rare, benign condition that involves the synovium of the joints, most commonly the knee. The condition also can affect the hip, ankle, shoulder, elbow, and temporomandibular joint.

View Article and Find Full Text PDF

Orthodontic Treatment of Anterior Open Bite Caused by a Car Accident.

Contemp Clin Dent

December 2024

Department of Orthodontics and Craniofacial Developmental Biology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

This article outlines the orthodontic treatment of a 21-year-old female patient with an open bite and temporomandibular joint disorders (TMDs) that developed after a severe car accident. The treatment plan utilized temporary anchorage devices (TADs) for upper molar intrusion to correct the open bite without resorting to orthognathic surgery. Over a period of 3 years, the treatment achieved a stable occlusion, normalized molar relationships, and improved esthetics.

View Article and Find Full Text PDF

Using platelet concentrates to treat maxillofacial tissue lesions.

Front Bioeng Biotechnol

January 2025

State Key Laboratory of Oral Diseases, Sichuan University, Chengdu, China.

Objectives: Platelet concentrates (PCs), which are blood products that are abundant in platelets and growth factors, have become pivotal in treating maxillofacial tissue lesions due to their capacity for promoting bone and soft tissue recovery. This review will provide some recent progress of the use of platelet concentrates to treat lesions on maxillofacial tissues.

Subjects: We reviewed the mechanisms by which PCs promote wound healing and tissue recovery and summarized the application of PCs in the treatment of lesions on maxillofacial tissues, including medication-related osteonecrosis of the jaw, post-extraction wound healing, implant surgery, temporomandibular joint diseases, and periodontal tissue restoration.

View Article and Find Full Text PDF

Orexin-A (OXA), a neuropeptide produced in the hypothalamus, is recognized for its role in modulating orofacial nociception and regulating feeding behaviors, as well as its impact on psychophysiological responses. This study investigated the role of orexin-1 receptors (OX1R) in modulating nociceptive behaviors induced by noxious stimulation of the temporomandibular joint (TMJ) and the associated changes in mood and feeding behaviors in rats with complete Freund's adjuvant (CFA)-induced temporomandibular disorders (TMDs). Bilateral cannulation of the lateral ventricles was performed in rats.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!